Important Notice regarding Dextenza and Klarity-C

Posted in Latest News on October 15, 2019.

During the September 27, 2019 Board of Optometry meeting, the Board approved Dextenza (dexamethasone ophthalmic insert) 0.4 mg and approved Klarity-C (cyclosporine) 0.1% for addition to Rule 64B13-18.002, Florida Administrative Code – Formulary of Topical Pharmaceutical Agents.

Important Note: At this time, Dextenza and Klarity-C cannot be prescribed by Certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on the board website and both may be prescribed by Certified Optometrists at that time.



More Latest News

Announcing the FY 2022-23 Annual Report and Long-Range Plan
November 1, 2023

An annual publication showcasing trends and information about Florida’s health care regulatory landscape. Continue reading


Hurricane Idalia: Early Prescription Refills Permitted Under State of Emergency
August 27, 2023

On August 26, 2023, Governor Ron DeSantis declared a state of emergency to prepare for Hurricane Idalia. Continue reading




Survey Button